本页面由Tiger Trade Technology Pte. Ltd.提供服务

ANI Pharmaceuticals, Inc.

73.89
+1.912.65%
盘后:73.890.00000.00%17:26 EDT
成交量:54.08万
成交额:3,984.11万
市值:16.97亿
市盈率:16.27
高:74.43
开:71.87
低:71.25
收:71.98
52周最高:97.00
52周最低:69.58
股本:2,297.04万
流通股本:2,028.20万
量比:1.50
换手率:2.67%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
净资产收益率:20.46%
总资产收益率:5.45%
市净率:2.84
市盈率(LYR):22.26

数据加载中...

2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

重要事件披露

Form 8-K - Current report
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/07

重要事件披露

Form 8-K - Current report